Table 3.
Univariate and multivariate analysis for MVI with HCC in the training group.
| Univariate Analysis |
Multivariate Analysis |
|||||
|---|---|---|---|---|---|---|
| Variables | OR | 95%CI | P value | OR | 95%CI | P value |
| Tumor size (>3/≤3 cm) | 6.9 | 3.0–16.1 | <0.001* | 4.1 | 1.3–12.9 | 0.02 * |
| Tumor margin (Nonsmooth/Smooth) | 3.0 | 1.2–7.6 | 0.02* | 4.4 | 1.1–18.0 | 0.04 * |
| Tumor shape (Irregular/ Regular) | 1.1 | 0.4–3.1 | 0.81 | |||
| NAPHE (Present/ Absent) | 1.1 | 0.3–3.5 | 0.90 | |||
| Nonperipheral washout | ||||||
| (Present/ Absent) | 2.1 | 0.5–8.4 | 0.27 | |||
| Enhancing capsule (Present/ Absent) | 1.0 | 0.3–3.8 | 1.00 | |||
| Nodule-in-nodule (Present/ Absent) | 10.2 | 1.2–87.8 | 0.03* | 2.2 | 0.1–40.3 | 0.59 |
| Mosaic architecture (Present/ Absent) | 4.1 | 1.9–9.1 | <0.001* | 3.2 | 1.0–9.6 | 0.04* |
| Blood products (Present/ Absent) | 1.9 | 0.7–5.2 | 0.24 | |||
| Fat in tumor (Present/ Absent) | 1.0 | 0.3–3.8 | 1.00 | |||
| Restricted diffusion (Present/ Absent) | 2.0 | 0.2–20.3 | 0.54 | |||
| Mild-moderate T2 hyperintensity | ||||||
| (Present/ Absent) | 2.0 | 0.2–20.3 | 0.54 | |||
| Corona enhancement (Present/ Absent) | 8.4 | 3.6–19.7 | <0.001* | 3.7 | 1.1–12.2 | 0.03* |
| Fat sparing in tumor | 1.1 | 0.2–5.3 | 0.87 | |||
| Iron sparing in tumor | 0.0 | 0-∞ | 0.99 | |||
| Rad-score | 108.1 | 17.2–680.7 | <0.001* | 10.2 | 1.0–102.2 | 0.04 * |